Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOW study (Low HDL on six Weeks statin therapy)
2004-001690-26Phase 4Completed
- Sponsor
- Craigavon Area Hospital Group Trust
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in lipid disorder comparing Niaspan arm with Placebo arm (2 arms). Primary endpoint: Proportion achieving target HDL-C. Started Sep 2005; status: completed.
02
Drugs
niacin
03
Conditions
lipid disorder
Beyond the preview
Go deeper on 2004-001690-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001690-26.